Ecstasy: Where The Feds Disagree

Since the early '90s, as more and more youths have discovered ecstasy, government scientists have tried to speak with a clear voice that the drug carries life-threatening risks and no benefits. Now that voice has cracked.

The FDA has sanctioned a study of methylenedioxymethamphetamine, better known as MDMA, or ecstasy, as a possible treatment for post-traumatic stress disorder. Once it is approved by a review board at a research facility, the study will mark the first time in three decades that the government has allowed researchers to give a psychedelic drug to subjects who have never taken it, which suggests the...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!